Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients
Table 2
Drugs predicted 14 times out of the 14 state changes investigated.
Drugs predicted 14 times out of the 14 state changes investigated.